<VariationArchive VariationID="842633" VariationName="NM_000194.3(HPRT1):c.22_27+28del" VariationType="Deletion" Accession="VCV000842633" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="853027" VariationID="842633">
      <GeneList>
        <Gene Symbol="HPRT1" FullName="hypoxanthine phosphoribosyltransferase 1" GeneID="3251" HGNC_ID="HGNC:5157" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.2-26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460165" stop="134500668" display_start="134460165" display_stop="134500668" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133594174" stop="133634697" display_start="133594174" display_stop="133634697" Strand="+" />
          </Location>
          <OMIM>308000</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HPRT1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC107032760" FullName="origin of replication in promoter/intron 1 of HPRT1" GeneID="107032760" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460082" stop="134465691" display_start="134460082" display_stop="134465691" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129929047" FullName="ATAC-STARR-seq lymphoblastoid silent region 21009" GeneID="129929047" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq26.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460257" stop="134460436" display_start="134460257" display_stop="134460436" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000194.3(HPRT1):c.22_27+28del</Name>
      <CanonicalSPDI>NC_000023.11:134460324:GCCCTGGCGTCGTGGTGAGCAGCTCGGCCTGCCGGCCCTGGC:GCCCTGGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="134460325" stop="134460358" display_start="134460325" display_stop="134460358" variantLength="34" positionVCF="134460324" referenceAlleleVCF="AGCCCTGGCGTCGTGGTGAGCAGCTCGGCCTGCCG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="133594355" stop="133594388" display_start="133594355" display_stop="133594388" variantLength="34" positionVCF="133594354" referenceAlleleVCF="AGCCCTGGCGTCGTGGTGAGCAGCTCGGCCTGCCG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.133594363_133594396del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.133594363_133594396del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046339.1" sequenceAccession="NG_046339" sequenceVersion="1" change="g.352_385del">
            <Expression>NG_046339.1:g.352_385del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000194.3" sequenceAccession="NM_000194" sequenceVersion="3" change="c.22_27+28del" MANESelect="true">
            <Expression>NM_000194.3:c.22_27+28del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.134460333_134460366del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.134460333_134460366del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012329.2" sequenceAccession="NG_012329" sequenceVersion="2" change="g.5189_5222del">
            <Expression>NG_012329.2:g.5189_5222del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2077579380" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000194.3(HPRT1):c.22_27+28del AND multiple conditions" Accession="RCV001045083" Version="5">
        <ClassifiedConditionList TraitSetID="10191">
          <ClassifiedCondition DB="MedGen" ID="C0023374">Lesch-Nyhan syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268117">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-12-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15571220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17027311</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22157001</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10191" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5209" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GOUT, HPRT-RELATED</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HPRT1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1 DEFICIENCY, PARTIAL</ElementValue>
                <XRef Type="MIM" ID="300323" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Partial hypoxanthine-guanine phosphoribosyltransferase deficiency</ElementValue>
                <XRef ID="Partial+hypoxanthine-guanine+phosphoribosyltransferase+deficiency/9096" DB="Genetic Alliance" />
                <XRef ID="238007004" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16710" />
                <XRef ID="16710" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <XRef ID="79233" DB="Orphanet" />
              <XRef ID="C0268117" DB="MedGen" />
              <XRef ID="MONDO:0010299" DB="MONDO" />
              <XRef Type="MIM" ID="300323" DB="OMIM" />
            </Trait>
            <Trait ID="5397" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lesch-Nyhan syndrome</ElementValue>
                <XRef ID="Lesch+Nyhan+syndrome/4181" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010298" DB="MONDO" />
                <XRef ID="10406007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LNS</ElementValue>
                <XRef Type="MIM" ID="300322" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">HPRT1 disorders, caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), are typically associated with clinical evidence for overproduction of uric acid (hyperuricemia, nephrolithiasis, and/or gouty arthritis) and varying degrees of neurologic and/or behavioral problems. Historically, three phenotypes were identified in the spectrum of HPRT1 disorders: Lesch-Nyhan disease (LND) at the most severe end with motor dysfunction resembling severe cerebral palsy, intellectual disability, and self-injurious behavior; HPRT1-related neurologic dysfunction (HND) in the intermediate range with similar but fewer severe neurologic findings than LND and no self-injurious behavior; and HPRT1-related hyperuricemia (HRH) at the mild end without overt neurologic deficits. It is now recognized that these neurobehavioral phenotypes cluster along a continuum from severe to mild.</Attribute>
                <XRef ID="NBK1149" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7226" />
                <XRef ID="7226" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301328</ID>
                <ID Source="BookShelf">NBK1149</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3039492</ID>
              </Citation>
              <XRef ID="510" DB="Orphanet" />
              <XRef ID="C0023374" DB="MedGen" />
              <XRef ID="MONDO:0010298" DB="MONDO" />
              <XRef Type="MIM" ID="300322" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2374202" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="7580185|MedGen:C0023374;C0268117" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001208913" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15571220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17027311</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22157001</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17027311</ID>
          </Citation>
          <Comment>The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant results in the deletion of part of exon 1 (c.22_27+28del) of the HPRT1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with HPRT1-related conditions. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in HPRT1 are known to be pathogenic (PMID: 15571220, 17027311, 22157001). This variant disrupts the c.27+5 nucleotide in the HPRT1 gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 17027311). This suggests that this nucleotide is clinically-significant, and that variants that disrupt this position are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPRT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.133594355_133594388del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023374" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268117" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2374202" TraitType="Disease" MappingType="XRef" MappingValue="C0268117" MappingRef="MedGen">
        <MedGen CUI="C0268117" Name="Partial hypoxanthine-guanine phosphoribosyltransferase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2374202" TraitType="Disease" MappingType="XRef" MappingValue="C0023374" MappingRef="MedGen">
        <MedGen CUI="C0023374" Name="Lesch-Nyhan syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

